EPISODE · Nov 29, 2022 · 11 MIN
Liquid biopsy offers noninvasive DNA testing for cancer care: Gang Zheng, M.D., Ph.D., and Aaron Mansfield, M.D.
from Answers from the Lab · host Mayo Clinic Laboratories
(00:31) Could you each provide us a little bit about yourself and your background? Dr. Zheng, we'll start with you.(01:40) Dr. Mansfield, how about you?(02:07) Could you explain a little bit about the new biopsy test and the technology?(03:58) Which patients should have this testing and when should it be used?(06:44) What alternative test options are available and how would they compare to the Mayo complete cell-free DNA panel?(08:28) Can you go into a little more detail from a clinical practice perspective about how these tests are used?(10:16) Dr. Zheng, is there anything else you would like to add to this discussion?(10:53) Dr. Mansfield, is there anything else you would like to add to this discussion?
What this episode covers
Gang Zheng, M.D., Ph.D., and Aaron Mansfield, M.D., describe Mayo Clinic Laboratories’ liquid biopsy, which analyzes blood samples for genetic information to guide cancer treatment. The circulating tumor DNA assay uses next generation sequencing and complements the laboratory's cell-based cancer testing.
NOW PLAYING
Liquid biopsy offers noninvasive DNA testing for cancer care: Gang Zheng, M.D., Ph.D., and Aaron Mansfield, M.D.
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.